Cannell & Co. Novartis Ag Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Novartis Ag stock. As of the latest transaction made, Cannell & Co. holds 3,674 shares of NVS stock, worth $422,583. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,674

Previous 4,545 19.16%

Holding current value

$422,583

Previous $462,000 19.91%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$92.27 - $101.54 $80,367 - $88,441	-871 Reduced 19.16%	3,674 $370,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $1,989 - $2,207	21 Added 0.46%	4,545 $462,000
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $14,988 - $16,995	-162 Reduced 3.46%	4,524 $456,000
Q1 2023 May 08, 2023	SELL	$80.03 - $92.81 $8,403 - $9,745	-105 Reduced 2.19%	4,686 $431,000
Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $6,421 - $7,864	85 Added 1.81%	4,791 $434,000
Q3 2022 Nov 02, 2022	SELL	$74.61 - $87.26 $29,097 - $34,031	-390 Reduced 7.65%	4,706 $358,000
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $32,208 - $37,500	-400 Reduced 7.28%	5,096 $431,000
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $79,700 - $88,130	-1,000 Reduced 15.39%	5,496 $481,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $174,273 - $202,743	-2,131 Reduced 24.7%	6,496 $531,000
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $102,288 - $112,980	-1,200 Reduced 12.21%	8,627 $787,000
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $96,025 - $113,240	-1,150 Reduced 10.48%	9,827 $840,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $98,568 - $109,200	-1,200 Reduced 9.85%	10,977 $955,000
Q1 2020 May 05, 2020	SELL	$70.67 - $99.01 $697,866 - $977,723	-9,875 Reduced 44.78%	12,177 $1 Million
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $86,458 - $97,754	1,025 Added 4.87%	22,052 $2.09 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $79,979 - $88,133	935 Added 4.65%	21,027 $1.83 Million
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $19,604 - $24,128	-260 Reduced 1.28%	20,092 $1.84 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $14,762 - $16,885	196 Added 0.97%	20,352 $1.96 Million
Q3 2018 Nov 05, 2018	SELL	$66.94 - $77.43 $45,184 - $52,265	-675 Reduced 3.24%	20,156 $1.74 Million
Q2 2018 Aug 06, 2018	BUY	$64.91 - $73.36 $6,491 - $7,336	100 Added 0.48%	20,831 $1.57 Million
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $96,152 - $114,948	-1,366 Reduced 6.18%	20,731 $1.68 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $1.64 Million - $1.71 Million	22,097	22,097 $1.9 Million

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $247B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account